Showing results (2261-2270 of 2,355) with videos related to
Sort By:
Pageof 236
Circulation|July 18, 2019
Insights Into the Pathogenesis of Catecholaminergic Polymorphic Ventricular Tachycardia From Engineered Human Heart TissueSung-Jin Park, Donghui Zhang, Yan Qi, et al.Preventive Medicine|May 11, 2018
Tobacco use in cardiac patients: Perceptions, use, and changes after a recent myocardial infarction among US adults in the PATH study (2013-2015)Diann E Gaalema, Irene Pericot-Valverde, Janice Y Bunn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional AssayChunling Hu, Lisa R Susswein, Maegan E Roberts, et al.Nature Communications|April 25, 2019
Sequencing of human genomes with nanopore technologyRory Bowden, Robert W Davies, Andreas Heger, et al.Journal of Pain and Symptom Management|March 13, 2024
EMPOWER: A Multi-Site Pilot Trial to Reduce Distress in Surrogate Decision-Makers in the ICUWendy G Lichtenthal, Lindsay Lief, Madeline Rogers, et al.Emerging Infectious Diseases|May 23, 2024
Emerging Variants of Canine Enteric Coronavirus Associated with Outbreaks of Gastroenteric DiseaseEdward Cunningham-Oakes, Jack Pilgrim, Alistair C Darby, et al.Nature Genetics|December 2, 1999
Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosisC Toomes, J James, A J Wood, et al.American Journal of Respiratory and Critical Care Medicine|December 13, 2005
Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertensionElisabeth D Willers, John H Newman, James E Loyd, et al.Journal of the National Cancer Institute|August 17, 2000
Randomized trial of a specialist genetic assessment service for familial breast cancerK Brain, J Gray, P Norman, et al.Journal of Medicinal Chemistry|October 29, 2000
N,N-Diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide: a novel, exceptionally selective, potent delta opioid receptor agonist with oral bioavailability and its analoguesZ Y Wei, W Brown, B Takasaki, et al.Pageof 236